S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer

S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1 monotherapy as neoadjuvant treatment. A 68-year-old man was diagnosed with gastric cancer and massive l...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Jong Yul, Rha, Sun Young, Ahn, Joong Bae, Yang, Woo Ick, Noh, Sung Hoon, Chung, Hyun Cheol, Jeung, Hei-Cheul
Formato: Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2008
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686958/
https://www.ncbi.nlm.nih.gov/pubmed/18363278
http://dx.doi.org/10.3904/kjim.2008.23.1.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2686958/
https://www.ncbi.nlm.nih.gov/pubmed/18363278
http://dx.doi.org/10.3904/kjim.2008.23.1.37

Ejemplares similares